Effect and mechanism of miR-195 regulates on proliferation and apoptosis of human breast cancer MCF-7 cells#br#
LIU Jiaqi1 ZHAI Fengguo1 GAO Jinxia2 LIU Jiawei3 YANG Xudong1 ZHOU Fubo1 LI Mengquan4▲
1.Department of Pharmacology, Mudanjiang Medical University, Heilongjiang Province, Mudanjiang 157011, China;
2.Department of Preventive Medicine, Mudanjiang Medical University, Heilongjiang Province, Mudanjiang 157011, China;
3.Department of Organic Chemistry, Mudanjiang Medical University, Heilongjiang Province, Mudanjiang 157011, China;
4.Medical Research Center, Mudanjiang Medical University, Heilongjiang Province, Mudanjiang 157011, China
Abstract：Objective To explore the role and mechanism of miR-195 in regulating proliferation and apoptosis of human breast cancer MCF-7 cells (MCF-7). Methods Breast epithelial cells MCF-10A (MCF-10A) and MCF-7 were cultured in vitro. The expression of miR-195 was detected by qRT-PCR. Protein expression of phosphatase magnesium-dependent 1 delta (PPM1D) was detected by Western blot (WB). Transient transfection of MCF-7 was carried out. 3-(4,5- two methyl thiazole -2)-2,5- two phenyl tetrazolium bromide (MTT) method and DNA breakage TdT-mediated-duTP nick end labeling method were used to observe the effect of miR-195 on proliferation and apoptosis of MCF-7. Double luciferase reporter genes were used to verify the relationship between miR-195 and PPM1D. Results The expression of miR-195 in MCF-7 group was lower than that in MCF-10A group, the expression of PPM1D protein in MCF-7 group was higher than that in MCF-10A group, the differences were statistically significant (P ＜ 0.05). The cell viability of miR-195 mimics group was lower than MCF-7 group; miR-195 inhabitor group was higher than MCF-7 group, the differences were highly statistically significant (P ＜ 0.01). The apoptosis rate of miR-195 mimics group was higher than MCF-7 group, the difference was highly statistically significant (P ＜ 0.01); and miR-195 inhabitor group was lower than MCF-7 group, the difference was statistically significant (P ＜ 0.05). Double luciferase reporter gene showed that miR-195 mimics group, which carried the PPM1D gene fragment, the activity of luciferase was lower than MCF-7 group , the difference was statistically significant (P ＜ 0.01). There was no significant difference in luciferase activity between the mir-195 MIMics group containing the mutated PPM1D gene fragment and McF-7 group (P ＞ 0.05). Conclusion miR-195 may regulate the proliferation and apoptosis of breast cancer cells through targeting PPM1D.
刘嘉祺1 翟凤国1 高金霞2 刘佳维3 杨旭东1 周福波1 李孟全4▲. miR-195调控人乳腺癌细胞MCF-7增殖与凋亡的作用及机制研究[J]. 中国医药导报, 2022, 19(1): 18-22.
LIU Jiaqi1 ZHAI Fengguo1 GAO Jinxia2 LIU Jiawei3 YANG Xudong1 ZHOU Fubo1 LI Mengquan4▲. Effect and mechanism of miR-195 regulates on proliferation and apoptosis of human breast cancer MCF-7 cells#br#. 中国医药导报, 2022, 19(1): 18-22.
[1] Liang Y，Song X，Li Y，et al. A novel long non-coding RNA-PRLB acts as a tumor promoter through regulating miR-4766-5p/SIRT1 axis in breast cancer [J]. Cell Death Dis，2018，9（5）：1-16.
[2] Serrano MJ，Rovira PS. Dynamics of circulating tumor cells in early breast cancer under neoadjuvant therapy [J]. Exp Ther Med，2012，4（1）：43-48.
[3] Fiscella M，Zhang H，Fan S，et al. Wip1，a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner [J]. Proc Nat Acad Sci USA，1997，94（12）：6048-6053.
[4] Lambros MB，Natrajan R，Geyer FC，et al. PPM1D gene amplification and overexpression in breast cancer：a qRT-PCR and chromogenic in situ hybridization study [J]. Mod Pathol，2010，23（10）：1334-1345.
[5] Parssinen J，Alarmo EL，Karhu R，et al. PPM1D silencing by RNA interference inhibits proliferation and induces apoptosis in breast cancer cell lines with wild-type p53 [J]. Cancer Genet Cytogenet，2008，182（1）：33-39.
[6] Bartel DP. MicroRNAs：target recognition and regulatory functions [J]. Cell，2009，136（6）：215-233.
[7] Fabian MR，Sonenberg N，Filipowicz W. Regulation of mRNA translation and stability by microRNAs [J]. Annu Rev Biochem，2010，79（10）：351-379.
[8] Zhou B，Sun C，Hu X，et al. MicroRNA-195 Suppresses the Progression of Pancreatic Cancer by Targeting DCLK1 [J]. Cell Physiol Biochem，2017，44（5）：1867-1881.
[9] Xu Z，Li C，Qu H，et al. MicroRNA-195 inhibits the proliferation and invasion of pancreatic cancer cells by targeting the fatty acid synthaseWnt signaling pathway [J]. Tumour Biol，2017，39（6）：283-324.
[10] Li X，Xin P，Wang C，et al. Mechanisms of traditional Chinese medicine in the treatment of mammary gland hyperplasia [J]. Am J Chin Med，2017，45（3）：443-458.
[11] Lin C，Xie L，Lu Y，et al. miR-133b reverses cisplatin resistance by targeting GSTP1 in cisplatin-resistant lung cancer cells [J]. Int J Mol Med，2018，41（4）：2050-2058.
[12] Yin Y，Cai J，Meng F，et al. MiR-144 suppresses proliferation，invasion and migration of breast cancer cells through inhibiting CEP55 [J]. Cancer Biol Ther，2018， 19（4）：306-315.
[13] Guoliang H，Wenfeng X，Yabin J，et al. MiRNA-217 accelerates the proliferation and migration of bladder cancer via inhibiting KMT2D [J]. Biochem Biophys Res Commun，2019，519（4）：747-753.
[14] Shen CJ，Cheng YM，Wang CL. LncRNA PVT1 epigenetically silences miR-195 and modulates EMT and chemoresistance in cervical cancer cells [J]. J Drug Target，2017， 25（7）：637-644.
[15] Qiang Q，Chu X，Peng W. MicroRNA-195 suppresses osteosarcoma cell proliferation and invasion by suppressing naked cuticle homolog [J]. Cell Bio Inter，2016，41（3）：287-295.
[16] Yang X，Yu J，Yin J，et al. MiR-195 regulates cell apoptosis of human hepatocellular carcinoma cells by targeting LATS2 [J]. Pharmazie，2012，67（7）：645-651.
[17] Liu L，Chen L，Xu Y，et al. microRNA-195 promotes apoptosis and suppresses tumorigenicity of human colorectal cancer cells [J]. Bioche-mical & Biophysical Research Communications，2010，400（2）：236-240.
[18] Liu C，Guan H，Wang Y，et al. miR-195 Inhibits EMT by Targeting FGF2 in Prostate Cancer Cells [J]. PLoS One，2015，10（12）：e0144073-e0144073.
[19] Jianhua L，Junsu P，Yan J，et al. MiR-195-5p Inhibits Proliferation and Induces Apoptosis of Non-Small Cell Lung Cancer Cells by Targeting CEP55 [J]. Onco Targets and Therapy，2019，12（12）：11465-11474.
[20] Wenhong D，Jieqing L，Kimberly D，et al. The role of PPM1D in cancer and advances in studies of its inhibitors [J]. Bio Pharm，2020，125（5）：109956-109956.
[21] Nathan R，Ranjini K，Gregory A，et al. PPM1D mutations silence NAPRT gene expression and confer NAMPT inhibitor sensitivity in glioma [J]. Nat Commun，2019，10（1）：3780-3790.
[22] Burocziova M，Burdova K，Martinikova AS，et al. Truncated PPM1D impairs stem cell response to genotoxic stress and promotes growth of APC-deficient tumors in the mouse colons [J]. Cell Death Dis，2019，10（11）：818-828.
[23] Ke L，Ying L，Shuning X，et al. PPM1D Functions as Oncogene and is Associated with Poor Prognosis in Esophageal Squamous Cell Carcinoma [J]. Pathol Oncol Res，2020，26（1）：387-395.
[24] Pechá■ková S，Burdová K，Macurek L. WIP1 phosphatase as pharmacological target in cancer therapy [J]. J Mol Med，2017，95（6）：589-599.
[25] Yin HL，Xu HW，Lin QY. miR129-1 regulates protein phosphatase 1D protein expression under hypoxic conditions in non-small cell lung cancer cells harboring a TP53 mutation [J]. Oncol Lett，2020，20（3）：2239-2247.
京公网安备 11010502046598号